Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TITAN PHARMACEUTICAL (TTP) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (236)	10/7/2002 8:03:50 PM
From: Miljenko Zuanic	Respond to of 362

<<This is really low. Many CEOs have derived wealth from a biotech without ever having built a business, but this is a new low IMO.>> Yes, many CEOs and their potatoes built huge wealth, and without even idea how to built business. I would like to know how many others took the some approach as he did, in 2000? I recommended to him 5 years free vacation in Hawaii (in 97), but he did outsmarted many investors (not me). Miljenko

To: scaram(o)uche who wrote (236)	10/8/2002 1:34:24 PM
From: Czechsinthemail	Respond to of 362

I've also become thoroughly disenchanted with TTP management. They have created a major credibility problem with no reason for shareholders to trust their stewardship. The only saving grace for TTP seems to be a low stock price relative to its cash and the possibility that they can salvage something from Iloperidone or get positive results from CeaVac. The latter two don't look like high probabilities, so there may be further downside when bad news arrives. Though theoretically the company could liquidate, given management's propensity for making their money on the dark side, it may be more likely that they will run the company through a slow bleed to oblivion. I think there are better opportunities with more reliable leadership elsewhere.